Insider Stock Trading History of Foehr Matthew W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Foehr Matthew W since year 2005. The trader's CIK number is 1237556. At the time of this reporting, Foehr Matthew W is the President and COO of Ligand Pharmaceuticals Inc . (stock ticker symbol LGND). See this page for all insider trading activities at Ligand Pharmaceuticals Inc .

Note that in the past FOEHR MATTHEW W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Foehr Matthew W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-09 LGND Ligand Pharmaceuticals Inc Option Ex 6,950 9.97 69,291
2017-08-09 LGND Ligand Pharmaceuticals Inc Sale 6,100 127.51 777,823
2017-05-18 RTTR Ritter Pharmaceuticals Inc Buy 18,000 .62 11,160
2017-05-12 LGND Ligand Pharmaceuticals Inc Sale 5,621 112.19 630,648
2017-05-15 LGND Ligand Pharmaceuticals Inc Option Ex 2,200 9.97 21,934
2017-05-12 LGND Ligand Pharmaceuticals Inc Option Ex 5,621 9.97 56,041
2017-03-02 LGND Ligand Pharmaceuticals Inc Option Ex 6,879 9.97 68,583
2017-03-03 LGND Ligand Pharmaceuticals Inc Option Ex 2,000 9.97 19,940
2017-03-02 LGND Ligand Pharmaceuticals Inc Sale 6,879 103.39 711,212
2016-11-15 VKTX Viking Therapeutics, Inc. Buy 13,000 1.21 15,678
2016-08-05 LGND Ligand Pharmaceuticals Inc Option Ex 12,500 9.97 124,625
2016-08-05 LGND Ligand Pharmaceuticals Inc Sale 12,500 122.14 1,526,750
2016-08-08 LGND Ligand Pharmaceuticals Inc Option Ex 4,125 9.97 41,126
2016-04-13 VKTX Viking Therapeutics, Inc. Buy 20,000 1.24 24,800
2016-03-17 LGND Ligand Pharmaceuticals Inc Option Ex 8,650 9.97 86,240
2016-03-17 LGND Ligand Pharmaceuticals Inc Sale 6,400 96.70 618,880
2016-01-08 RTTR Ritter Pharmaceuticals Inc Buy 13,000 1.64 21,320
2015-06-26 LGND Ligand Pharmaceuticals Inc Sale 12,500 100.97 1,262,125
2015-06-29 LGND Ligand Pharmaceuticals Inc Option Ex 2,500 9.97 24,925
2015-06-26 LGND Ligand Pharmaceuticals Inc Option Ex 12,500 9.97 124,625
2015-06-24 RTTR Ritter Pharmaceuticals Inc Buy 4,000 5.00 20,000
2015-06-22 LGND Ligand Pharmaceuticals Inc Option Ex 25,046 9.97 249,708
2015-06-22 LGND Ligand Pharmaceuticals Inc Sale 23,046 96.56 2,225,252
2015-05-04 VKTX Viking Therapeutics, Inc. Buy 6,250 8.00 50,000
2014-12-31 LGND Ligand Pharmaceuticals Inc Buy 46 45.23 2,080
2014-10-10 LGND Ligand Pharmaceuticals Inc Buy 85 44.91 3,817
2014-10-13 LGND Ligand Pharmaceuticals Inc Option Ex 1,000 9.97 9,970
2014-06-30 LGND Ligand Pharmaceuticals Inc Buy 428 43.79 18,742
2014-02-14 LGND Ligand Pharmaceuticals Inc Sale 22,500 79.54 1,789,650
2014-02-14 LGND Ligand Pharmaceuticals Inc Option Ex 25,944 9.97 258,661
2013-12-31 LGND Ligand Pharmaceuticals Inc Buy 84 33.91 2,848
2013-12-12 LGND Ligand Pharmaceuticals Inc Option Ex 6,000 9.97 59,820
2013-12-12 LGND Ligand Pharmaceuticals Inc Sale 6,000 53.40 320,400
2013-06-28 LGND Ligand Pharmaceuticals Inc Buy 1,059 17.36 18,384
2012-12-05 LGND Ligand Pharmaceuticals Inc Buy 370 17.99 6,655
2006-03-01 CNCT Connetics Corp Option Ex 3,800 12.45 47,310
2006-03-01 CNCT Connetics Corp Sale 3,800 16.46 62,548
2006-02-03 CNCT Connetics Corp Option Ex 5,250 8.46 44,441
2006-02-03 CNCT Connetics Corp Sale 12,250 14.99 183,627

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Foehr Matthew W (President and COO of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.